UPDATE 2-U.S. FDA advisers back Novartis malaria drug -
UPDATE 1-U.S. FDA panel backs Novartis malaria drug -
Novartis malaria drug safe and effective-US FDA panel -
Novartis wins big in German generics tenders -sources -
Europe approves Alcon's Azarga glaucoma treatment -
UPDATE 1-Novartis, Mylan agree on Femara generic -
BRIEF-Novartis confirms Femara agreement with Mylan -
Swiss stocks - Factors to watch on Dec 2 -
UPDATE 2-Data supports Novartis malaria drug -US FDA staff -
BRIEF-Novartis sees approval of afinitor in Q1 -
UPDATE 1-Novartis malaria drug safe, effective-US FDA staff -
Novartis malaria drug safe, effective-US FDA staff -
UPDATE 2-Novartis might up dividend in future- CEO tells TV -
UPDATE 1-Novartis CEO sees higher dividend in future - TV -
BRIEF-Novartis CEO sees higher dividend in future - TV -
DJ Novartis Will Probably Raise Its Dividend For 2008 - Report -
Novartis CEO sees pressure on drug sector - report -
BRIEF-Novartis, AstraZeneca not aware of fresh EU inspections -
European stocks end at 5-1/2 year closing low -